These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18237604)

  • 1. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.
    Bhattacharyya S; Toumpanakis C; Caplin ME; Davar J
    Am J Cardiol; 2008 Feb; 101(3):378-81. PubMed ID: 18237604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of patent foramen ovale in carcinoid heart disease.
    Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
    Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
    Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
    Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale in carcinoid heart disease.
    Mansencal N; Touhami I; Mitry E; Rougier P; Dubourg O
    Int J Cardiol; 2010 Jul; 142(2):e29-31. PubMed ID: 19157592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
    Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
    Pellikka PA; Tajik AJ; Khandheria BK; Seward JB; Callahan JA; Pitot HC; Kvols LK
    Circulation; 1993 Apr; 87(4):1188-96. PubMed ID: 7681733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
    Hayashi Y; McGaw DJ; Goldstein J
    Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoid heart disease with right to left shunt across a patent foramen ovale: a case report and review of literature.
    Chowdhury MA; Taleb M; Kakroo MA; Tinkel J
    Echocardiography; 2015 Jan; 32(1):165-9. PubMed ID: 24976489
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
    Zuetenhorst JM; Korse CM; Bonfrer JM; Bakker RH; Taal BG
    Br J Cancer; 2004 Jun; 90(11):2073-9. PubMed ID: 15150565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.
    Mansencal N; McKenna WJ; Mitry E; Beauchet A; Pellerin D; Rougier P; Dubourg O
    Am J Cardiol; 2010 Feb; 105(4):527-31. PubMed ID: 20152249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.
    Boglioli LR; Gardiner J; Gerstenblith G; Taff ML; Cameron DE
    Tex Heart Inst J; 1997; 24(2):125-8. PubMed ID: 9205988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report.
    Khay K; Arous S; Bentaoune T; Drighil A; Habbal R
    J Med Case Rep; 2018 Jan; 12(1):23. PubMed ID: 29386066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular abnormalities in patients with a carcinoid syndrome.
    Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
    Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive dyspnoea in two patients with carcinoid syndrome].
    Nölting S; Nicolaus M; Behr J; Baumgartner R; Mete H; Boekstegers P; Herrmann K; Theisen D; Lehrke M; Göke B; Schirra J; Auernhammer CJ
    Internist (Berl); 2010 Nov; 51(11):1439-45. PubMed ID: 20628718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and evolution of carcinoid syndrome in the heart.
    Moyssakis IE; Rallidis LS; Guida GF; Nihoyannopoulos PI
    J Heart Valve Dis; 1997 Nov; 6(6):625-30. PubMed ID: 9427132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tricuspid insufficiency disclosing carcinoid syndrome].
    Monségu J; Algayres JP; Ciribilli JM; Bussière JL; Duriez P; Gaillard JF; Daly JP
    Rev Med Interne; 1994; 15(9):593-6. PubMed ID: 7984839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI and CT revealing carcinoid heart disease.
    Mollet NR; Dymarkowski S; Bogaert J
    Eur Radiol; 2003 Dec; 13 Suppl 6():L14-8. PubMed ID: 16440219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with carcinoid heart disease after valvular surgery.
    Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
    Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
    Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic follow-up of treated patients with carcinoid syndrome.
    Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
    Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.